leisure time -WSS

leisure time

author：explore 2025-09-29 21:13:29 - browse：497

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

Wikipedia

hotspot

WSS

Medicare isn't yet testing food as medicine

Opioid cravings were reduced by anti

NEJM study measures Covid brain fog, impact on IQ

As AI regulations shape up, health tech startups beg for clarity

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Redefining sustainability for the pharmaceutical industry

explore

leisure time

focus

Supreme Court strikes down use of affirmative action

Are embryos people? Reproductive medicine's future depends on the answer

Tori Bowie and the unacceptable rates of Black maternal death

Surprise medical billing ban raises prices elsewhere

The cancer drug shortage isn’t new — and neither are the solutions

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

MD Anderson's Padmanee Sharma responds to research credit suit

Guidelines to prevent youth baseball injuries need more muscle

Children’s Hospital revives plan for pedestrian bridge

entertainment

Laying a path for careers in science

A new drug could help frostbite victims avoid its ravages

Medicare isn't yet testing food as medicine

New study raises questions about niacin and heart health

CDC panel: People 65 and older should get a Covid spring booster shot

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

explore

Wikipedia

hotspot

focus